Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Xiangpu Wang"'
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 1, p 637 (2024)
The microgravity conditions in outer space are widely acknowledged to induce significant bone loss. Recent studies have implicated the close relationship between Atp6v1h gene and bone loss. Despite this, the role of Atp6v1h in bone remodeling and its
Externí odkaz:
https://doaj.org/article/3b1ffa7e65624743a6fe312420eb0d4d
Publikováno v:
Oral Diseases.
Publikováno v:
AIAA SCITECH 2023 Forum.
Publikováno v:
Journal of Periodontal Research. 55:182-190
Background and objective It has been reported that long non-coding RNAs (lncRNAs), such as metastasis-associated lung adenocarcinoma transcript 1 (MALAT1), act as key regulators of the development of inflammatory diseases. However, it is unclear whet
Background: Currently, no systematic analysis has been conducted to assess the potential of multiple autophagy-related long non-coding RNAs (lncRNA) to predict the prognosis of head and neck squamous cell carcinoma (HNSCC). we investigated the progno
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9bf85a81e91a116806b26615568aaddf
https://doi.org/10.21203/rs.3.rs-892575/v1
https://doi.org/10.21203/rs.3.rs-892575/v1
Publikováno v:
International Journal of General Medicine
Background Non-syndromic cleft lip with or without cleft palate (NSCL/P) is a common craniofacial birth defect. Growing evidence has demonstrated the competing endogenous RNA (ceRNA) hypothesis has played a role in the pathogenesis of NSCL/P. Here, w
Publikováno v:
Bioscience reports. 42(2)
Aim: The main of the present study was to investigate the role of insulin-like growth factor 2 mRNA-binding protein 2 (IGF2BP2) in oral squamous cell carcinoma (OSCC) with the overarching of providing new biomarkers or potential therapeutic targets f
Publikováno v:
Bioscience Reports; Feb2022, Vol. 42 Issue 2, p1-19, 19p
Autor:
Lun-Quan Sun, Deyun Feng, Guolin Tan, Qingqing Liu, Bowen Xie, Xiangpu Wang, Jing Zhang, Lu Zhang, Xinhui Yang, Zhijiao Zhou, Nianhua Ding
Publikováno v:
Cancer Letters. 363:137-145
Paclitaxel (Taxol) is currently used as the front-line chemotherapeutic drug for many types of human cancers. However, the emergence of drug resistance has been a major obstacle to the effective treatment of cancers in clinical settings. The transcri